Vector Acquisition Corporation 10-Q Summary
Important scope note: This is Vector Acquisition Corporation’s SPAC filing, not an operating-company 10-Q for Rocket Lab. It reports Vector’s financial position and the proposed Rocket Lab combination; it does not provide Rocket Lab’s standalone quarterly operating results.
Business context and reporting period
The unaudited report covers the quarter and six months ended June 30, 2021. Vector was a blank-check company with no operating business or revenue. It had signed a merger agreement with Rocket Lab USA, Inc.; the transaction was subject to closing conditions and was then expected to close in Q3 2021.
Financial results and liquidity
- Revenue: None; Vector said it would not generate operating revenue before a business combination.
- Net loss: $1.06 million for Q2 2021 and $24.62 million for the first half of 2021. Operating costs were $1.15 million and $3.08 million, respectively.
- Non-operating items: First-half results included a $21.55 million noncash loss from the increase in warrant liabilities, partly offset by $9,673 of trust-account interest. Q2 included an $81,333 gain from warrant remeasurement and $4,863 of interest.
- Cash flow: Operating activities used $821,057 in the first half. Cash outside the trust account fell to $44,846 from $865,903 at December 31, 2020.
- Trust and liquidity: Trust-account investments were $320.01 million, substantially intended for the business combination, subject to shareholder redemptions and transaction terms. Management said outside cash was insufficient for anticipated obligations over the next year, but expected Sponsor funding to cover working-capital needs.
- Liabilities and equity: Total liabilities were $59.71 million, including $46.12 million of warrant liabilities and an $11.20 million deferred underwriting fee payable if a combination closes. Shareholders’ equity was negative $59.36 million; $320 million of Class A shares were presented as temporary equity because they were redeemable.
- Debt: No working-capital loans were outstanding at June 30, 2021. The filing disclosed a later Sponsor note allowing borrowing of up to $300,000; the document gives inconsistent dates for its issuance (July 19 in MD&A and August 1 elsewhere).
- Margins: Not meaningful for this non-operating SPAC. The filing provides no Rocket Lab revenue, profit, cash-flow, or margin figures.
Material changes and transaction outlook
- Compared with December 31, 2020, warrant liabilities increased from $24.56 million to $46.12 million, mainly reflecting fair-value changes. This noncash remeasurement was a major driver of the first-half loss.
- Accrued expenses rose to $2.39 million from $217,395. Trust investments remained approximately $320 million.
- The proposed combination contemplated a $4.0 billion aggregate share-consideration calculation, subject to specified adjustments, and a concurrent PIPE investment of 46.7 million shares at $10 each, or $467 million gross, contingent on closing. Rocket Lab management share redemptions could total up to $40 million.
- Rocket Lab stockholders could receive additional shares if the post-closing stock-price condition of at least $20 per share for 20 of 30 trading days during the specified post-closing period is met.
- Vector’s business-combination deadline was September 29, 2022. If it failed to complete a transaction by then, public shares generally would be redeemed from the trust; warrants could expire worthless.
Risks, controls, and unusual items
- Vector reported that disclosure controls were ineffective as of June 30, 2021, solely due to the prior-period restatement to classify warrants as liabilities. Remediation steps had been taken but were not complete.
- Warrant fair values are remeasured each reporting period, so reported gains or losses may fluctuate materially without corresponding cash effects.
- The filing cited uncertainty about COVID-19 effects on the company and the proposed combination, without quantifying a specific impact. Completion also depended on customary closing conditions, PIPE funding, and redemptions.
- Management disclosed no pending or contemplated litigation known to it and no off-balance-sheet financing arrangements.
Key facts for investors to verify
- Whether the Rocket Lab transaction and the $467 million PIPE financing closed, and the final cash proceeds after redemptions and transaction costs.
- Rocket Lab’s standalone operating results, cash position, debt, and forecasts; they are not presented in this SPAC filing.
- The final share consideration, management redemptions, and any earnout shares tied to the $20 stock-price condition.
- The status of the control-deficiency remediation and the accounting and fair value of outstanding warrants.
- The correct date and actual borrowing, if any, under the Sponsor’s $300,000 working-capital note.